Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent

Christian Billard1, Faouzia Menasria, Claire Quiney

  • 1INSERM U872 (équipe 18), Université Pierre et Marie Curie-Paris 6, Paris, France. cbillard@bhdc.jussieu.fr

Leukemia Research
|November 6, 2007
PubMed

Insights

Flavopiridol induces apoptosis in chronic lymphocytic leukemia (CLL) cells by downregulating inducible nitric oxide synthase (iNOS). This effect is caspase-dependent, suggesting flavopiridol enhances cell cycle-dependent therapies for CLL.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Chronic lymphocytic leukemia (CLL) cells exhibit resistance to apoptosis.
  • Flavopiridol has shown potential in inducing apoptosis in CLL cells ex vivo.
  • Previous studies linked flavopiridol-induced apoptosis to downregulation of inducible nitric oxide synthase (iNOS) and p27kip1.

Purpose of the Study:

  • To elucidate the role of inducible nitric oxide synthase (iNOS) downregulation in flavopiridol-induced apoptosis of CLL cells.
  • To determine if iNOS downregulation is a primary event or an effector mechanism in flavopiridol-induced apoptosis.
  • To investigate the effect of flavopiridol on the cell cycle of CLL cells and its implications for combination therapy.

Main Methods:

  • Ex vivo culture of CLL patient cells.
  • Treatment with flavopiridol.
  • Assessment of caspase activity.
  • Analysis of inducible nitric oxide synthase (iNOS) expression and activity.
  • Cell cycle analysis using flow cytometry.

Main Results:

  • Flavopiridol-induced downregulation of iNOS is dependent on caspase activation, indicating it is an effector mechanism of apoptosis.
  • iNOS downregulation is not the primary triggering event for flavopiridol-induced apoptosis.
  • Flavopiridol promotes the entry of a subpopulation of CLL cells into the S and G2 phases of the cell cycle.

Conclusions:

  • Flavopiridol-induced iNOS downregulation is a downstream consequence of apoptosis, mediated by caspases.
  • Flavopiridol's ability to modulate the cell cycle suggests a potential synergistic effect with cell cycle-dependent therapies in CLL treatment.
  • These findings support the investigation of flavopiridol in combination strategies for managing CLL.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...